Releases Saturday 8 February 2003
No 7384 Volume 326

Please remember to credit the BMJ as source when publicising an
article and to tell your readers that they can read its full text on the
journal's web site (http://bmj.com).

If your story is posted on a website please include a link back to
the source BMJ article (URL's are given under titles).


(1) COMMUNICATING WITH YOUNG PEOPLE
WHO ARE SERIOUSLY ILL IS DIFFICULT

(2) USE PUBLIC FUNDS TO TEST JET LAG DRUG,
SAY RESEARCHERS

(3) POLICE, NOT SOCIAL WORKERS, SHOULD
PROTECT CHILDREN FROM CRIMINAL ABUSE

(4) LEGAL AND ETHICAL CONCERNS OVER
PRENATAL DIAGNOSIS



(1) COMMUNICATING WITH YOUNG PEOPLE
WHO ARE SERIOUSLY ILL IS DIFFICULT

(Managing communication with young people who have
a potentially life threatening chronic illness: qualitative
study of patients and parents )
http://bmj.com/cgi/content/full/326/7384/305

Young people who are seriously ill can feel unable to
participate in consultations and parents may be reluctant
to communicate openly with their children. Health
professionals must try to balance the different priorities
of young people and parents, suggest researchers in this
week's BMJ.

Thirteen cancer patients aged 8-17 years, and their
parents, gave accounts of communication about their
illness.

Most parents described acting in an executive-like role,
managing what and how their children were told about
their illness, particularly at the time of diagnosis when
parents faced the difficult job of dealing with their own
emotional responses. Their accounts were shaped by
concerns to manage their identity as strong and optimistic
parents and to protect their child's wellbeing.

While the young people welcomed their parents'
involvement, some felt that communication was
constrained by their parents' role. One patient aged 15
said: " I still didn't feel that they were telling me
everything." Some young people described feeling
marginalised in consultations and pointed to difficulties
they experienced in encounters with some doctors.

The young people in our study clearly wanted their
parents to be involved in communication but were not
always satisfied with how communication was managed,
say the authors.

Professionals need to remain aware of how the power
relations of professional-parent-child encounters can be
an obstacle in forging successful relationships between
health professionals and young people. These issues will
be of crucial importance in implementing the new
children's national service framework, they conclude.

Contact:

Bridget Young, Lecturer, Department of Psychology,
University of Hull, UK
Email: B.Young@hull.ac.uk

(2) USE PUBLIC FUNDS TO TEST JET LAG DRUG,
SAY RESEARCHERS

(Editorial: The prevention and treatment of jet lag)
http://bmj.com/cgi/content/full/326/7384/296

The hormone melatonin has long been used to prevent
and treat jet lag, but in many countries it cannot be sold
because it is not licensed. Researchers in this week's
BMJ argue that if use of the drug is in the public interest,
then public funds should be used to get it adequately
tested to be licensed.

Jet lag is caused by the disturbance of normal body
rhythms as a result of flying across different time zones.
Melatonin plays a part in controlling daily body rhythms.

A recent review found 10 randomised controlled trials
comparing melatonin with placebo in long distance
travellers. Eight of the 10 trials found a clear reduction in
jet lag when melatonin had been taken.

The review concludes that 2-5mg melatonin taken at
bedtime after arrival is effective and may be worth
repeating for the next two to four days, together with
several behavioural measures to adjust the body clock.

In the United States, Thailand, and Singapore, melatonin
is freely sold as a "dietary supplement" in health food
stores and pharmacies, although no official standards of
purity exist. In Europe, Australia, and many other
countries, melatonin is defined as a medicine and
requires a licence, but no licensed preparation is
marketed; only the internet offers a grey or black
market.

It seems that many people and organisations, including
governments and armed forces, would benefit from the
use of melatonin to reduce jet lag, say the authors. If use
of the drug is in the public interest, then public funds
should be used to get it properly tested and licensed. A
finance initiative is urgently needed to solve the problem
and might best begin with a cost benefit assessment, they
conclude.

Contact:

Andrew Herxheimer, Emeritus Fellow, UK Cochrane
Centre, London, UK
Email: andrew_herxheimer@compuserve.com

(3) POLICE, NOT SOCIAL WORKERS, SHOULD
PROTECT CHILDREN FROM CRIMINAL ABUSE

(Personal view: The police should take the lead on
protecting children from criminal abuse)
http://bmj.com/cgi/content/full/326/7384/343

Following Lord Laming's report on the life and death of
Victoria Climbie, paediatricians experienced in managing
life threatening abuse suggest in this week's BMJ that
police, rather than social workers, should take
responsibility for protecting children from criminal abuse.

Professor David Southall and colleagues believe that
most perpetrators, knowing they are committing crimes,
deceive and intimidate social and health workers. If
criminal abuse is likely, then the police must lead and be
responsible for the child protection process, they say.

They draw on recent papers they have written
concerning a new way of looking at child ill-treatment,
including a suggestion that special inter-agency task
forces on criminal abuse are established and run by
experienced and adequately resourced police units. They
will best ensure that, as Lord Laming expects "the
standard of investigation into criminal offences against
children" will be "as rigorous as the investigation of
similar crimes against adults."

There is already a major shortage of social workers in
poor areas, and paediatricians, who are often the first to
identify a potentially abuse child, are becoming less
willing to initiate proceedings. Failure to protect
professionals in order to appease parents and the public
will continue to deter frontline workers from speaking
out, they warn.

In addition, Lord Laming's report does not address the
way in which abusers are increasingly adept at using
complaints procedures and the media to attack
professionals.

Addressing the criminal abuse of children must be a
priority, not only in England, but in the majority of
countries that do not have any child protection systems
and where many thousands of children like Victoria are
cruelly enslaved and exploited every day. We need an
international response to criminal abuse ? namely, an
effective police led protection force, they conclude.

Contact:

David Southall, Professor of Paediatrics, North
Staffordshire Hospital, Staffordshire, UK
Email: davids@doctors.org.uk

(4) LEGAL AND ETHICAL CONCERNS OVER
PRENATAL DIAGNOSIS

(Prenatal diagnosis requests for Huntington's disease
when the father is at risk and does not want to know his
genetic status: clinical, legal, and ethical viewpoints)
http://bmj.com/cgi/content/full/326/7384/331

Hospital genetics units occasionally receive requests
from women for prenatal tests for Huntington's disease
when their male partners are at risk but do not want to
know their genetic status for the disease. In this week's
BMJ, researchers discuss the legal and ethical concerns
that these cases raise.

Cases like these pose considerable ethical and legal
dilemmas for clinicians, write the authors. Does the right
of the pregnant mother to know the status of her fetus
outweigh the right of the father at risk to not know his
genetic status?

In a clinical ethics consultation, the lawyer and ethicist
presented the clinical team with their ideas on the subject
and had the team reconsider its procedures in light of the
different viewpoints.

The clinical team's preferred course of action was to test
the male partner first, and, if he was found to have the
mutation, to offer prenatal diagnosis. Alternatively,
exclusion testing (testing to exclude the risk of the
condition in the fetus) preserves the man's preference to
not know his status for being at risk. Both these options
involve the man in the decision making processes,
thereby meeting his needs for information and emotional
support.

Should clinicians breach confidentiality to directly
determine the views of the man who is at risk? Under
Australian law, decisions about prenatal testing can be
made solely by the mother. The father's consent (or even
knowledge) is not required because the law states that
these are tests on her body, explain the authors.

The final decision of whether or not the test should be
done is up to the judgement of clinicians; a court will not
override their decision, regardless of the woman's
wishes.

There is no easy answer to such requests, say the
authors. The law in Australia and the United Kingdom
may need to be reconsidered and perhaps clarified by
legislation, while clinical teams need to deal with them on
the basis of the individual circumstances.

Contact:

Martin Delatycki, Clinical Geneticist, Genetic Health
Services, Victoria Royal Children's Hospital, Victoria,
Australia
Email: delatycm@cryptic.rch.unimelb.edu.au


FOR ACCREDITED JOURNALISTS

Embargoed press releases and articles are available from:

Public Affairs Division
BMA House
Tavistock Square
London WC1H 9JR
(contact: pressoffice@bma.org.uk)

and from:

the EurekAlert website, run by the American Association for the
Advancement of Science
(http://www.eurekalert.org)